1. Home
  2. RLAY vs IRS Comparison

RLAY vs IRS Comparison

Compare RLAY & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.15

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)

IRS

IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)

HOLD

Current Price

$15.72

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
IRS
Founded
2015
1943
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
RLAY
IRS
Price
$9.15
$15.72
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$15.75
N/A
AVG Volume (30 Days)
2.5M
199.4K
Earning Date
02-24-2026
02-04-2026
Dividend Yield
N/A
8.75%
EPS Growth
N/A
N/A
EPS
N/A
0.38
Revenue
$8,355,000.00
$351,014,223.00
Revenue This Year
$19.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.85
Revenue Growth
N/A
2.09
52 Week Low
$1.78
$10.61
52 Week High
$9.25
$19.14

Technical Indicators

Market Signals
Indicator
RLAY
IRS
Relative Strength Index (RSI) 59.52 40.50
Support Level $8.08 $15.52
Resistance Level $9.25 $16.47
Average True Range (ATR) 0.67 0.93
MACD 0.12 -0.24
Stochastic Oscillator 83.02 4.97

Price Performance

Historical Comparison
RLAY
IRS

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)

IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.

Share on Social Networks: